Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$384.55
-1.67-0.43%
At close: -
$384.55
0.000.00%
After Hours: Jun 13, 4:00 PM EDT
Comments
Loading...
Elevance Health Analyst Ratings and Price Targets | NYSE:ELV | Benzinga
Elevance Health Inc has a consensus price target of $535.68 based on the ratings of 26 analysts. The high is $631 issued by JP Morgan on May 30, 2024. The low is $405.4 issued by Argus Research on January 29, 2025. The 3 most-recent analyst ratings were released by Truist Securities, RBC Capital, and Barclays on June 9, 2025, June 4, 2025, and June 2, 2025, respectively. With an average price target of $486 between Truist Securities, RBC Capital, and Barclays, there's an implied 26.38% upside for Elevance Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
RBC Capital
Barclays
Guggenheim
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Elevance Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/09/2025 | Buy Now | 30.02% | Truist Securities | David Macdonald64% | $510 → $500 | Maintains | Buy | Get Alert |
| 06/04/2025 | Buy Now | 24.3% | RBC Capital | Ben Hendrix60% | $478 → $478 | Reiterates | Outperform → Outperform | Get Alert |
| 06/02/2025 | Buy Now | 24.82% | Barclays | Andrew Mok56% | $522 → $480 | Maintains | Overweight | Get Alert |
| 04/23/2025 | Buy Now | 24.3% | RBC Capital | Ben Hendrix60% | $478 → $478 | Reiterates | Outperform → Outperform | Get Alert |
| 04/23/2025 | Buy Now | 34.7% | Guggenheim | Jason Cassorla47% | $518 → $518 | Reiterates | Buy → Buy | Get Alert |
| 04/23/2025 | Buy Now | 26.12% | Cantor Fitzgerald | Sarah James50% | $485 → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 04/23/2025 | Buy Now | 35.74% | Barclays | Andrew Mok56% | $512 → $522 | Maintains | Overweight | Get Alert |
| 04/15/2025 | Buy Now | 37.56% | Baird | Michael Ha39% | $625 → $529 | Downgrade | Outperform → Neutral | Get Alert |
| 04/11/2025 | Buy Now | 32.62% | Truist Securities | David Macdonald64% | $480 → $510 | Maintains | Buy | Get Alert |
| 04/09/2025 | Buy Now | 34.7% | Guggenheim | Jason Cassorla47% | → $518 | Initiates | → Buy | Get Alert |
| 04/09/2025 | Buy Now | 31.32% | Mizuho | Ann Hynes86% | $455 → $505 | Maintains | Outperform | Get Alert |
| 01/29/2025 | Buy Now | 5.42% | Argus Research | David Toung69% | $405.4 → $405.4 | Reiterates | Hold → Hold | Get Alert |
| 01/28/2025 | Buy Now | 24.3% | Wells Fargo | Stephen Baxter51% | $483 → $478 | Maintains | Overweight | Get Alert |
| 01/24/2025 | Buy Now | 26.12% | Cantor Fitzgerald | Sarah James50% | $485 → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2025 | Buy Now | 33.14% | Barclays | Andrew Mok56% | $501 → $512 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | 24.82% | Truist Securities | David Macdonald64% | $520 → $480 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 31.32% | Mizuho | Ann Hynes86% | $585 → $505 | Maintains | Outperform | Get Alert |
| 11/04/2024 | Buy Now | 28.72% | Wells Fargo | Stephen Baxter51% | $593 → $495 | Maintains | Overweight | Get Alert |
| 10/23/2024 | Buy Now | 43.28% | Morgan Stanley | Erin Wright75% | $643 → $551 | Maintains | Overweight | Get Alert |
| 10/22/2024 | Buy Now | 30.28% | Barclays | Andrew Mok56% | $622 → $501 | Maintains | Overweight | Get Alert |
| 10/21/2024 | Buy Now | 25.86% | TD Cowen | Ryan Langston26% | $589 → $484 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | — | Argus Research | — | — | Downgrade | Buy → Hold | Get Alert |
| 10/18/2024 | Buy Now | 44.32% | UBS | A.J. Rice69% | $605 → $555 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | 35.22% | Truist Securities | David Macdonald64% | $620 → $520 | Reiterates | Buy → Buy | Get Alert |
| 10/18/2024 | Buy Now | 24.3% | RBC Capital | Ben Hendrix60% | $585 → $478 | Maintains | Outperform | Get Alert |
| 10/18/2024 | Buy Now | 26.12% | Cantor Fitzgerald | Sarah James50% | $600 → $485 | Maintains | Overweight | Get Alert |
| 10/10/2024 | Buy Now | 61.75% | Barclays | Andrew Mok56% | $611 → $622 | Maintains | Overweight | Get Alert |
| 10/01/2024 | Buy Now | 56.03% | Cantor Fitzgerald | Sarah James50% | $600 → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 09/20/2024 | Buy Now | 56.03% | Cantor Fitzgerald | Sarah James50% | $600 → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 09/10/2024 | Buy Now | 56.03% | Cantor Fitzgerald | Sarah James50% | $600 → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2024 | Buy Now | 59.93% | Stephens & Co. | Scott Fidel68% | $615 → $615 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 56.03% | Cantor Fitzgerald | Sarah James50% | $600 → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 07/23/2024 | Buy Now | 56.03% | Cantor Fitzgerald | Sarah James50% | $600 → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | 54.21% | Wells Fargo | Stephen Baxter51% | $600 → $593 | Maintains | Overweight | Get Alert |
| 07/19/2024 | Buy Now | 53.17% | TD Cowen | Ryan Langston26% | $624 → $589 | Maintains | Buy | Get Alert |
| 07/18/2024 | Buy Now | 58.89% | Barclays | Andrew Mok56% | $621 → $611 | Maintains | Overweight | Get Alert |
| 07/18/2024 | Buy Now | 52.13% | RBC Capital | Ben Hendrix60% | $575 → $585 | Maintains | Outperform | Get Alert |
| 07/18/2024 | Buy Now | 37.82% | B of A Securities | Kevin Fischbeck66% | $646 → $530 | Downgrade | Buy → Neutral | Get Alert |
| 07/15/2024 | Buy Now | 61.23% | Truist Securities | David Macdonald64% | $600 → $620 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 56.03% | Cantor Fitzgerald | Sarah James50% | $600 → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 06/24/2024 | Buy Now | 67.21% | Morgan Stanley | Erin Wright75% | → $643 | Initiates | → Overweight | Get Alert |
| 06/12/2024 | Buy Now | 56.03% | Cantor Fitzgerald | Sarah James50% | $600 → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 06/11/2024 | Buy Now | 59.93% | Stephens & Co. | Scott Fidel68% | $615 → $615 | Reiterates | Overweight → Overweight | Get Alert |
| 06/04/2024 | Buy Now | 67.99% | B of A Securities | Kevin Fischbeck66% | $621 → $646 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 64.09% | JP Morgan | Lisa Gill55% | $628 → $631 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 68.77% | Baird | Michael Ha39% | → $649 | Initiates | → Outperform | Get Alert |
| 04/24/2024 | Buy Now | 52.13% | Mizuho | Ann Hynes86% | $575 → $585 | Maintains | Buy | Get Alert |
| 04/19/2024 | Buy Now | 49.53% | RBC Capital | Ben Hendrix60% | $574 → $575 | Maintains | Outperform | Get Alert |
| 04/19/2024 | Buy Now | 57.33% | UBS | A.J. Rice69% | $585 → $605 | Maintains | Buy | Get Alert |
| 04/19/2024 | Buy Now | 56.03% | Wells Fargo | Stephen Baxter51% | $557 → $600 | Maintains | Overweight | Get Alert |
| 04/19/2024 | Buy Now | 56.03% | Truist Securities | David Macdonald64% | $580 → $600 | Reiterates | Buy → Buy | Get Alert |
| 04/19/2024 | Buy Now | 57.07% | Jefferies | David Windley73% | $602 → $604 | Maintains | Buy | Get Alert |
| 04/19/2024 | Buy Now | 61.49% | Barclays | Andrew Mok56% | $584 → $621 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 50.83% | Cantor Fitzgerald | Sarah James50% | $580 → $580 | Reiterates | Overweight → Overweight | Get Alert |
| 04/08/2024 | Buy Now | 44.84% | Wells Fargo | Stephen Baxter51% | $561 → $557 | Maintains | Overweight | Get Alert |
| 04/04/2024 | Buy Now | 50.83% | Cantor Fitzgerald | Sarah James50% | $580 → $580 | Reiterates | Overweight → Overweight | Get Alert |
| 03/06/2024 | Buy Now | 51.87% | Barclays | Andrew Mok56% | → $584 | Initiates | → Overweight | Get Alert |
| 02/14/2024 | Buy Now | 50.83% | Cantor Fitzgerald | Sarah James50% | $547 → $580 | Maintains | Overweight | Get Alert |
| 02/02/2024 | Buy Now | 42.24% | Cantor Fitzgerald | Sarah James50% | $547 → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 01/25/2024 | Buy Now | 42.24% | Cantor Fitzgerald | Sarah James50% | $547 → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 01/25/2024 | Buy Now | 49.27% | RBC Capital | Ben Hendrix60% | $572 → $574 | Maintains | Outperform | Get Alert |
| 01/19/2024 | Buy Now | 42.24% | Cantor Fitzgerald | Sarah James50% | $547 → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 11/21/2023 | Buy Now | 42.24% | Cantor Fitzgerald | Sarah James50% | → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 43.54% | JP Morgan | Lisa Gill55% | $569 → $552 | Maintains | Overweight | Get Alert |
| 10/19/2023 | Buy Now | 42.24% | Cantor Fitzgerald | Sarah James50% | → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 10/19/2023 | Buy Now | 52.65% | Morgan Stanley | Michael Ha39% | $585 → $587 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | 42.24% | Cantor Fitzgerald | Sarah James50% | → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 07/25/2023 | Buy Now | 52.13% | Morgan Stanley | Michael Ha39% | $571 → $585 | Maintains | Overweight | Get Alert |
| 07/24/2023 | Buy Now | 52.13% | TD Cowen | Gary Taylor58% | $564 → $585 | Maintains | Outperform | Get Alert |
| 07/20/2023 | Buy Now | 48.75% | RBC Capital | Ben Hendrix60% | → $572 | Reiterates | Outperform → Outperform | Get Alert |
| 07/20/2023 | Buy Now | 44.32% | Stephens & Co. | Scott Fidel68% | → $555 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | 49.53% | UBS | Kevin Caliendo71% | $610 → $575 | Maintains | Buy | Get Alert |
| 07/12/2023 | Buy Now | — | Wolfe Research | Justin Lake31% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 07/07/2023 | Buy Now | 39.12% | JP Morgan | Lisa Gill55% | $572 → $535 | Maintains | Overweight | Get Alert |
| 06/20/2023 | Buy Now | 45.62% | Truist Securities | Tobey Sommer71% | $580 → $560 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 48.49% | Morgan Stanley | Michael Ha39% | $500 → $571 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/24/2023 | Buy Now | 45.88% | Wells Fargo | Stephen Baxter51% | $597 → $561 | Maintains | Overweight | Get Alert |
| 04/21/2023 | Buy Now | 43.02% | Loop Capital | Joseph France64% | $565 → $550 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | 42.24% | Cantor Fitzgerald | Sarah James50% | → $547 | Initiates | → Overweight | Get Alert |
| 04/20/2023 | Buy Now | 46.66% | TD Cowen | Gary Taylor58% | $577 → $564 | Maintains | Outperform | Get Alert |
| 03/28/2023 | Buy Now | 48.75% | RBC Capital | Ben Hendrix60% | $523 → $572 | Upgrade | Sector Perform → Outperform | Get Alert |
| 03/24/2023 | Buy Now | 50.83% | Truist Securities | Tobey Sommer71% | $610 → $580 | Maintains | Buy | Get Alert |
| 03/21/2023 | Buy Now | -81.54% | Wells Fargo | Stephen Baxter51% | $79 → $71 | Maintains | Equal-Weight | Get Alert |
| 03/08/2023 | Buy Now | 48.49% | Deutsche Bank | George Hill60% | $581 → $571 | Maintains | Buy | Get Alert |
| 02/23/2023 | Buy Now | 48.75% | JP Morgan | Lisa Gill55% | $555 → $572 | Maintains | Overweight | Get Alert |
| 01/26/2023 | Buy Now | 36% | RBC Capital | Ben Hendrix60% | $505 → $523 | Maintains | Sector Perform | Get Alert |
| 01/26/2023 | Buy Now | 50.83% | SVB Leerink | Whit Mayo66% | → $580 | Reiterates | → Outperform | Get Alert |
| 01/04/2023 | Buy Now | 58.37% | Wells Fargo | Stephen Baxter51% | $557 → $609 | Maintains | Overweight | Get Alert |
| 11/10/2022 | Buy Now | 49.53% | Mizuho | Ann Hynes86% | $545 → $575 | Maintains | Buy | Get Alert |
| 10/21/2022 | Buy Now | 51.09% | Deutsche Bank | George Hill60% | $576 → $581 | Maintains | Buy | Get Alert |
| 10/21/2022 | Buy Now | 30.02% | Morgan Stanley | Ricky Goldwasser78% | $485 → $500 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | Buy Now | 49.53% | B of A Securities | Kevin Fischbeck66% | $535 → $575 | Upgrade | Neutral → Buy | Get Alert |
| 08/22/2022 | Buy Now | 50.83% | SVB Leerink | Whit Mayo66% | $490 → $580 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/28/2022 | Buy Now | 44.84% | Wells Fargo | Stephen Baxter51% | $580 → $557 | Maintains | Overweight | Get Alert |
| 07/25/2022 | Buy Now | 26.12% | Morgan Stanley | Ricky Goldwasser78% | $533 → $485 | Maintains | Equal-Weight | Get Alert |
| 07/22/2022 | Buy Now | 27.42% | SVB Leerink | Whit Mayo66% | $555 → $490 | Maintains | Market Perform | Get Alert |
FAQ
What is the target price for Elevance Health (ELV) stock?
The latest price target for Elevance Health (NYSE:ELV) was reported by Truist Securities on June 9, 2025. The analyst firm set a price target for $500.00 expecting ELV to rise to within 12 months (a possible 30.02% upside). 41 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Elevance Health (ELV)?
The latest analyst rating for Elevance Health (NYSE:ELV) was provided by Truist Securities, and Elevance Health maintained their buy rating.
When was the last upgrade for Elevance Health (ELV)?
The last upgrade for Elevance Health Inc happened on April 27, 2023 when Morgan Stanley raised their price target to $571. Morgan Stanley previously had an equal-weight for Elevance Health Inc.
When was the last downgrade for Elevance Health (ELV)?
The last downgrade for Elevance Health Inc happened on April 15, 2025 when Baird changed their price target from $625 to $529 for Elevance Health Inc.
When is the next analyst rating going to be posted or updated for Elevance Health (ELV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elevance Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elevance Health was filed on June 9, 2025 so you should expect the next rating to be made available sometime around June 9, 2026.
Is the Analyst Rating Elevance Health (ELV) correct?
While ratings are subjective and will change, the latest Elevance Health (ELV) rating was a maintained with a price target of $510.00 to $500.00. The current price Elevance Health (ELV) is trading at is $384.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
